Challenges in transfusion and the role of Thalidomide in E‐β‐Thalassemia—A case report

Hemoglobin E‐β‐thalassemia is a common β‐thalassemia that has a variable presentation from mild to severe life‐threatening anemia. We describe such a case, who presented with severe anemia and multiple allo‐antibodies. Our case illustrates the role of thalidomide in transfusion‐sparing therapies in patients with transfusion‐dependent thalassemia and challenges in the blood bank.

[1]  M. Chandy,et al.  Thalidomide in Patients with Transfusion-Dependent E-Beta Thalassemia Refractory to Hydroxyurea: A Single-Center Experience , 2020, Indian Journal of Hematology and Blood Transfusion.

[2]  Sandip Shah,et al.  Safety and effectiveness of thalidomide and hydroxyurea combination in β‐thalassaemia intermedia and major: a retrospective pilot study , 2019, British journal of haematology.

[3]  M. Porteus,et al.  Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus. , 2018, Blood.

[4]  E. Angelucci,et al.  Dramatic erythroid response to low‐dose thalidomide in two patients with transfusion independent thalassemia and severe post‐transfusional alloimmune hemolysis , 2015, American journal of hematology.

[5]  S. Ferdowsi,et al.  RBC alloimmunization and double alloantibodies in thalassemic patients , 2015, Hematology.

[6]  M. Shahjahani,et al.  Evaluation of Novel Fetal Hemoglobin Inducer Drugs in Treatment of β-Hemoglobinopathy Disorders , 2013, International journal of hematology-oncology and stem cell research.

[7]  S. Masoud,et al.  Evaluation the Effect of Thalidomide and Sodium Butyrate on Cord Blood Stem Cell Differentiation Induction to Erythroid Lineage , 2011 .

[8]  G. Masera,et al.  Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy. , 2010, Blood transfusion = Trasfusione del sangue.

[9]  S. Al-Shemmari,et al.  RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients , 2003, Transfusion.

[10]  S. Rajkumar,et al.  Management of thalidomide toxicity. , 2003, The journal of supportive oncology.